7707 GATEWAY BLVD., SUITE 140, NEWARK, CA
Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Protagonist Therapeutics Approves 2026 Equity Incentive Plan at Annual Meeting
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
COMPANY OVERVIEW President & CEO January 12, 2026
Financial Results, Press Release
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
S-8 POS